期刊文献+

艾司西酞普兰对广泛性焦虑患者的疗效观察 被引量:3

The clinical observation of escitalopram on patients with generalized anxiety disorder
下载PDF
导出
摘要 目的观察艾司西酞普兰对广泛性焦虑患者疗效及不良反应的影响。方法将100例广泛性焦虑患者随机分为实验组与对照组,每组50例。实验组予艾司西酞普兰片口服15mg/d,对照组予艾司西酞普兰模拟剂15mg/d,两组进行6周的治疗,采用汉密尔顿焦虑量表(HAMA)评价疗效,抗抑郁药副反应评定量表(SERS)评定艾司西酞普兰的不良反应。结果与对照组比较,治疗后实验组HAMA评分明显下降(P<0.01);实验组治疗的总有效率为70%(35例),对照组为30%(15例),两组比较差异有统计学意义(P<0.01)。结论艾司西酞普兰对广泛性焦虑患者的疗效显著,安全性高。 Objective To observe the efficacy and adverse reactions of escitalopram on patients with generalized anxi- ety disorder. Methods One hundred patients with generalized anxiety were randomly divided into two groups, the ex- perimental group and the control group, and each group had 50 cases. The experimental group received escitalopram tablet 15 mg/d, the control group received escitalopram simulation agent 15 rag/d, and two groups were treated for 6 weeks. The efficacy was assessed by using Hamilton Anxiety Scale (HAMA) and the escitalopram adverse reaction was assessed by using antidepressant Side Effects Rating Scale (SERS). Results Compared with the control group, the ex- perimental group% HAMA score decreased significantly after treatment (P 〈 0.01); The total effective rate of the exper- imental group was 70% (35 cases), and that of the control group was 30% (15 cases), and there was significant differ- ence between the two groups (P 〈 0.01). Conclusion Escitalopram on patients with generalized anxiety disorder has obvious curative effect and high safety.
出处 《中国当代医药》 2013年第5期58-58,60,共2页 China Modern Medicine
关键词 艾司西酞普兰 广泛性焦虑 疗效 观察 Escitalopram Generalized anxiety disorder Curative effect Observation
  • 相关文献

参考文献6

  • 1Wagner W,Iabormy BA,Gray TE. Fluvoxamine:A review of its safety profile in worldwide studies[J].International Clinical Psycho Pharmacology,1994.222.
  • 2袁勇贵,吴爱琴,张心保.从焦虑和抑郁的关系谈共病的诊断[J].国外医学(精神病学分册),2001,28(1):17-19. 被引量:46
  • 3Rush AJ,Bose A. Escitalopram in clinical practice:results of an open-label trial in a naturalistic setting[J].DePression and Anxiety,2005,(01):26-32.
  • 4Davidson JR,Bose A,Korotzer A. Escitalopram in the treatment of generalized anxiety disorder:double-blind,placebo controlled,flexible-dose study[J].DePression and Anxiety,2004,(04):234-240.doi:10.1002/da.10146.
  • 5Kasper S,Stein DJ,Loft H. Escitalopram in the treatment of social anxiety disorder:randomised,placebo-controlled,flexible-dosage study[J].British Journal of Psychiatry,2005.222-226.
  • 6张红梅,梁炜,张红亚.艾司西酞普兰与西酞普兰治疗广泛性焦虑障碍对照研究[J].中国新药与临床杂志,2009,28(5):364-367. 被引量:36

二级参考文献7

  • 1中华医学会精神科学会 南京医科大学脑科医院.CCMD-2-R[M].南京:东南大学出版社,1995.69.
  • 2BRKEU WJ. Escitalopram[J]. Expert Opin Investig Drugs, 2002, 11(10): 1477-1486.
  • 3BIELSKI RJ, BOSE A, CHANG CC. A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder[J]. Ann Clin Psychiatry, 2005, 17 (2) : 65-69.
  • 4MURDOCH D, KEAM SJ. Eseitalopram: a review of its use in the management of major depressive disorder[J]. Drugs, 2005, 65(16) : 2379-2404.
  • 5GORMAN JM, KOROTZER A, SU G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials [J]. CNS Spectr,2002, 7(4 Suppl 1): 40-44.
  • 6马现仓,伏炜,陈策.西酞普兰与帕罗西汀治疗广泛性焦虑对照研究[J].临床精神医学杂志,2007,17(5):325-326. 被引量:7
  • 7陈珺,宋敏,杭太俊,王丽,文爱东,杨林.艾司西酞普兰在健康人体的药动学[J].中国新药与临床杂志,2007,26(12):912-916. 被引量:9

共引文献80

同被引文献13

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部